Grants and Contributions:

Back to search

Title:

AI-driven robotic ultrasound system for streamlined lymph node analysis in excised cancer tissues.

Agreement Number:

1021809

Agreement Value:

$200,000.00

Agreement Date:

Apr 1, 2024 - Mar 17, 2025

Description:

In colorectal cancer, staging is crucial for patient survival. Current healthcare systems often fail at accurate staging, leading to poor outcomes and higher costs. The process requires manually searching for lymph nodes (LNs) in tissues removed during surgery, a task that is time-consuming (30 mins to over 2 hours), expensive, and often misses small LNs, risking incorrect treatment. To solve this problem, Tenomix is developing a platform combining robotics, ultrasound, and AI to automate LN detection, making the process quicker, cheaper, and more accurate. This will aid pathology labs and improve treatment decisions. The current project focuses on advancing this technology, preparing for regulatory filing in 2025.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

London, Ontario, CA N6A 5K8

Reference Number:

172-2024-2025-Q2-1021809

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

786613109

Recipient Type:

For-profit organization

Recipient's Operating Name:

Tenomix

Recipient's Legal Name:

TENOMIX INC.

Federal Riding Name:

London North Centre

Federal Riding Number:

35052

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

33451